| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10919132 | Radiotherapy and Oncology | 2013 | 6 Pages |
Abstract
Preventive LLLT in HNSCC patients receiving chemoradiotherapy is an effective tool for reducing the incidence of grade 3-4 OM. Efficacy data were corroborated by improvements seen in quality of life.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Heliton S. Antunes, Daniel Herchenhorn, Isabele A. Small, Carlos M.M. Araújo, Celia Maria Pais Viégas, Elida Cabral, Mariana P. Rampini, Pedro C. Rodrigues, Tereza G.P. Silva, Elza M.S. Ferreira, Fernando L. Dias, Carlos G. Ferreira,